Trials / Conditions / EGFR Exon 19 Deletion
EGFR Exon 19 Deletion
4 registered clinical trials studyying EGFR Exon 19 Deletion — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO) NCT05998993 | Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo | N/A |
| Active Not Recruiting | HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally NCT05338970 | Daiichi Sankyo | Phase 3 |
| Terminated | (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC NCT05153408 | Blueprint Medicines Corporation | Phase 1 |
| Terminated | (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC NCT04862780 | Blueprint Medicines Corporation | Phase 1 |